Antimicrobial peptides are ubiquitous in multicellular organisms and have served as
defense mechanisms for their successful evolution and throughout their life cycle. These …

Pseudomonas aeruginosa infections represent a serious threat to worldwide health. Proline-
rich antimicrobial peptides (PR-AMPs), a particular group of peptide antibiotics, have …

The emergence of carbapenem-resistant Acinetobacter baumannii and Pseudomonas
aeruginosa raises fears of untreatable infections and poses the greatest health threats …

Gram-negative bacteria are becoming resistant to almost all currently available antibiotics.
Systemically designed antimicrobial peptides (AMPs) are attractive agents to enhance the …

Overuse of conventional antibiotics as well as the slow pace of new antibiotic drug
development leads to antimicrobial resistance (AMR). Because infections with multi‐drug …

Antimicrobial peptides (AMPs) have been isolated and characterized from tissues and
organisms representing virtually every kingdom and phylum. Their amino acid composition …

Antimicrobial peptides (AMPs), with their extraordinary properties, such as broad-spectrum
activity, rapid action and difficult development of resistance, have become promising …

Cationic antibacterial peptides have been proclaimed as new drugs against multiresistant
bacteria. Their limited success so far is partially due to the size of the peptides, which gives …

Antimicrobial peptides (AMPs) are an essential part of innate immunity. These compounds
have been considered as potential therapeutics because of their broad-spectrum activities …

Pathogenic superbugs are the root cause of untreatable complex infections with limited or
no treatment options. These infections are becoming more common as clinical antibiotics …